Human IL18RAP/ACPL/CD218b ORF/cDNA clone-Lentivirus plasmid (NM_003853)
Cat. No.: pGMLP002125
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IL18RAP/ACPL/CD218b Lentiviral expression plasmid for IL18RAP lentivirus packaging, IL18RAP lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
IL18RAP/CD218b/IL18RAP/ACPL products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP002125 |
| Gene Name | IL18RAP |
| Accession Number | NM_003853 |
| Gene ID | 8807 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 1800 bp |
| Gene Alias | ACPL,CD218b,CDw218b,IL-18R-beta,IL-18RAcP,IL-18Rbeta,IL-1R-7,IL-1R7,IL-1RAcPL,IL18RB |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCTCTGTTTGGGCTGGATATTTCTTTGGCTTGTTGCAGGAGAGCGAATTAAAGGATTTAATATTTCAGGTTGTTCCACAAAAAAACTCCTTTGGACATATTCTACAAGGAGTGAAGAGGAATTTGTCTTATTTTGTGATTTACCAGAGCCACAGAAATCACATTTCTGCCACAGAAATCGACTCTCACCAAAACAAGTCCCTGAGCACCTGCCCTTCATGGGTAGTAACGACCTATCTGATGTCCAATGGTACCAACAACCTTCGAATGGAGATCCATTAGAGGACATTAGGAAAAGCTATCCTCACATCATTCAGGACAAATGTACCCTTCACTTTTTGACCCCAGGGGTGAATAATTCTGGGTCATATATTTGTAGACCCAAGATGATTAAGAGCCCCTATGATGTAGCCTGTTGTGTCAAGATGATTTTAGAAGTTAAGCCCCAGACAAATGCATCCTGTGAGTATTCCGCATCACATAAGCAAGACCTACTTCTTGGGAGCACTGGCTCTATTTCTTGCCCCAGTCTCAGCTGCCAAAGTGATGCACAAAGTCCAGCGGTAACCTGGTACAAGAATGGAAAACTCCTCTCTGTGGAAAGGAGCAACCGAATCGTAGTGGATGAAGTTTATGACTATCACCAGGGCACATATGTATGTGATTACACTCAGTCGGATACTGTGAGTTCGTGGACAGTCAGAGCTGTTGTTCAAGTGAGAACCATTGTGGGAGACACTAAACTCAAACCAGATATTCTGGATCCTGTCGAGGACACACTGGAAGTAGAACTTGGAAAGCCTTTAACTATTAGCTGCAAAGCACGATTTGGCTTTGAAAGGGTCTTTAACCCTGTCATAAAATGGTACATCAAAGATTCTGACCTAGAGTGGGAAGTCTCAGTACCTGAGGCGAAAAGTATTAAATCCACTTTAAAGGATGAAATCATTGAGCGTAATATCATCTTGGAAAAAGTCACTCAGCGTGATCTTCGCAGGAAGTTTGTTTGCTTTGTCCAGAACTCCATTGGAAACACAACCCAGTCCGTCCAACTGAAAGAAAAGAGAGGAGTGGTGCTCCTGTACATCCTGCTTGGCACCATCGGGACCCTGGTGGCCGTGCTGGCGGCGAGTGCCCTCCTCTACAGGCACTGGATTGAAATAGTGCTGCTGTACCGGACCTACCAGAGCAAGGATCAGACGCTTGGGGATAAAAAGGATTTTGATGCTTTCGTATCCTATGCAAAATGGAGCTCTTTTCCAAGTGAGGCCACTTCATCTCTGAGTGAAGAACACTTGGCCCTGAGCCTATTTCCTGATGTTTTAGAAAACAAATATGGATATAGCCTGTGTTTGCTTGAAAGAGATGTGGCTCCAGGAGGAGTGTATGCAGAAGACATTGTGAGCATTATTAAGAGAAGCAGAAGAGGAATATTTATCTTGAGCCCCAACTATGTCAATGGACCCAGTATCTTTGAACTACAAGCAGCAGTGAATCTTGCCTTGGATGATCAAACACTGAAACTCATTTTAATTAAGTTCTGTTACTTCCAAGAGCCAGAGTCTCTACCTCATCTCGTGAAAAAAGCTCTCAGGGTTTTGCCCACAGTTACTTGGAGAGGCTTAAAATCAGTTCCTCCCAATTCTAGGTTCTGGGCCAAAATGCGCTACCACATGCCTGTGAAAAACTCTCAGGGATTCACGTGGAACCAGCTCAGAATTACCTCTAGGATTTTTCAGTGGAAAGGACTCAGTAGAACAGAAACCACTGGGAGGAGCTCCCAGCCTAAGGAATGGTGA |
| ORF Protein Sequence | MLCLGWIFLWLVAGERIKGFNISGCSTKKLLWTYSTRSEEEFVLFCDLPEPQKSHFCHRNRLSPKQVPEHLPFMGSNDLSDVQWYQQPSNGDPLEDIRKSYPHIIQDKCTLHFLTPGVNNSGSYICRPKMIKSPYDVACCVKMILEVKPQTNASCEYSASHKQDLLLGSTGSISCPSLSCQSDAQSPAVTWYKNGKLLSVERSNRIVVDEVYDYHQGTYVCDYTQSDTVSSWTVRAVVQVRTIVGDTKLKPDILDPVEDTLEVELGKPLTISCKARFGFERVFNPVIKWYIKDSDLEWEVSVPEAKSIKSTLKDEIIERNIILEKVTQRDLRRKFVCFVQNSIGNTTQSVQLKEKRGVVLLYILLGTIGTLVAVLAASALLYRHWIEIVLLYRTYQSKDQTLGDKKDFDAFVSYAKWSSFPSEATSSLSEEHLALSLFPDVLENKYGYSLCLLERDVAPGGVYAEDIVSIIKRSRRGIFILSPNYVNGPSIFELQAAVNLALDDQTLKLILIKFCYFQEPESLPHLVKKALRVLPTVTWRGLKSVPPNSRFWAKMRYHMPVKNSQGFTWNQLRITSRIFQWKGLSRTETTGRSSQPKEW |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T71362-Ab | Anti-I18RA/ IL18RAP/ ACPL monoclonal antibody |
| Target Antigen | GM-Tg-g-T71362-Ag | IL18RAP VLP (virus-like particle) |
| ORF Viral Vector | pGMLP002125 | Human IL18RAP Lentivirus plasmid |
| ORF Viral Vector | vGMLP002125 | Human IL18RAP Lentivirus particle |
Target information
| Target ID | GM-T71362 |
| Target Name | IL18RAP/CD218b |
|
Gene Group Identifier (Target Gene ID in Homo species) |
8807 |
| Gene ID |
100050212 (Equus caballus), 101084868 (Felis catus), 16174 (Mus musculus), 373540 (Rattus norvegicus) 481327 (Canis lupus familiaris), 493716 (Bos taurus), 712046 (Macaca mulatta), 8807 (Homo sapiens) |
| Gene Symbols & Synonyms | IL18RAP,Il18rap,AcPL,IL-18RAcP,IL-1RAcPL,IL-18Rbeta,IL-18R-beta,ACPL,CD218b,IL-1R7,IL18RB,CDw218b,IL-1R-7 |
| Target Alternative Names | ACPL,AcPL,Accessory protein-like (AcPL),CD218 antigen-like family member B,CD218b,CDw218b,IL-18 receptor accessory protein,IL-18R-beta,IL-18RAcP,IL-18Rbeta,IL-18Rbeta),IL-1R accessory protein-like (IL-1RAcPL),IL-1R-7,IL-1R7,IL-1R7),IL-1RAcPL,IL18RAP,IL18RB,Il18rap,Interleukin-1 receptor 7 (IL-1R-7,Interleukin-18 receptor accessory protein,Interleukin-18 receptor accessory protein-like,Interleukin-18 receptor beta (IL-18R-beta |
| Uniprot Accession |
O95256,Q9Z2B1
Additional SwissProt Accessions: Q9Z2B1,O95256 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Inflammatory bowel disease |
| Gene Ensembl | ENSECAG00000000214, ENSMUSG00000026068, ENSCAFG00845010356, ENSBTAG00000033748, ENSMMUG00000009246, ENSG00000115607 |
| Target Classification | Cytokine Receptor |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


